Quality Indicators in Barrett’s Esophagus: Time to Change the Status Quo
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The push for high quality care in all fields of medicine highlights the importance of establishing and adhering to quality indicators. In response, several gastrointestinal societies have established quality indicators specific to Barrett’s esophagus, which serve to createthresholds for performance while standardizing practice and guiding value-based care. Recent studies, however, have consistentlydemonstrated the lack of adherence to these quality indicators, particularly in surveillance (appropriate utilization of endoscopy andobtaining biopsies using the Seattle protocol) and endoscopic eradication therapy practices. These findings suggest that innovativeinterventions are needed to address these shortcomings in order to deliver high quality care to patients with Barrett’s esophagus.
Abstract
The push for high quality care in all fields of medicine highlights the importance of establishing and adhering to quality indicators. In response, several gastrointestinal societies have established quality indicators specific to Barrett’s esophagus, which serve to createthresholds for performance while standardizing practice and guiding value-based care. Recent studies, however, have consistentlydemonstrated the lack of adherence to these quality indicators, particularly in surveillance (appropriate utilization of endoscopy andobtaining biopsies using the Seattle protocol) and endoscopic eradication therapy practices. These findings suggest that innovativeinterventions are needed to address these shortcomings in order to deliver high quality care to patients with Barrett’s esophagus.
참고문헌 (35)
- Fitzgerald RC, "British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus", Gut, 63, pp.7~42 (2014)[DOI]
- Wani S, "Risk factors for progression of lowgrade dysplasia in patients with Barrett's esophagus", Gastroenterology, 141, pp.1179~1186 (2011)[DOI]
- Thrift AP, "Barrett's esophagus and esophageal adenocarcinoma: how common are they really?", Dig Dis Sci, 63, pp.1988~1996 (2018)[DOI]
- Sharma P, "Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium", Gastroenterology, 149, pp.1599~1606 (2015)[DOI]
- Wani S, "Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium", Gastrointest Endosc, 86, pp.1~17 (2017)[DOI]
- Wani S, "Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium", Am J Gastroenterol, 112, pp.1032~1048 (2017)[DOI]
- Institute of Medicine, "America's health in transition: protecting and improving quality" (1994), National Academies Press
- Rubenstein JH, "Measuring the quality of Barrett's esophagus management with measures that are high quality", Gastroenterology, 149, pp.1298~1301 (2015)[DOI]
- Rizk MK, "Quality indicators common to all GI endoscopic procedures", Gastrointest Endosc, 81, pp.3~16 (2015)[DOI]
- Sharma P, "The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria", Gastroenterology, 131, pp.1392~1399 (2006)[DOI]
- Vogt JS, "Quality of endoscopic surveillance of Barrett's esophagus", Scand J Gastroenterol, 53, pp.256~259 (2018)[DOI]
- Han S, "Factors associated with suboptimal adherence to quality indicators in Barrett's esophagus", Gastroenterology, 154(6 Suppl 1), pp.S~140 (2018)
- Ooi J, "Dedicated Barrett's surveillance sessions managed by trained endoscopists improve dysplasia detection rate", Endoscopy, 49, pp.524~528 (2017)[DOI]
- Sharma P, "Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial", Gut, 62, pp.15~21 (2013)[DOI]
- Shaheen NJ, "Less is more: a minimalist approach to endoscopy", Gastroenterology, 154, pp.1993~2003 (2018)[DOI]
- Wani SB, "Over-utilization of repeat upper endoscopy in patients with non-dysplastic Barrett's esophagus: a population-based study using a national benchmarking registry", Gastroenterology, 154(6 Suppl 1), pp.S28~S29 (2018)
- Tavakkoli A, "Use of appropriate surveillance for patients with nondysplastic Barrett's esophagus", Clin Gastroenterol Hepatol, 16, pp.862~869 (2018)[DOI]
- Desai TK, "The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis", Gut, 61, pp.970~976 (2012)[DOI]
- Abrams JA, "Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States", Clin Gastroenterol Hepatol, 7, pp.736~742 (2009)[DOI]
- Westerveld D, "Adherence to quality indicators and surveillance guidelines in the management of Barrett's esophagus: a retrospective analysis", Endosc Int Open, 6, pp.E300~E307 (2018)[DOI]
- Wani SB, "Endoscopists biopsy the least those who need it the most: an analysis of Barrett's esophagus biopsy practices from a national quality benchmarking registry", Gastrointest Endosc, 87(6 Suppl), pp.AB114~ (2018)
- Wani SB, "Regional variations and trends in quality indicator (QI) performance in Barrett's esophagus (BE): results from a population-based study using a national benchmarking registry", Gastrointest Endosc, 87(6 Suppl), pp.AB537~ (2018)
- Curvers WL, "Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated", Am J Gastroenterol, 105, pp.1523~1530 (2010)[DOI]
- Qumseya BJ, "Disease progression in Barrett's low-grade dysplasia with radiofrequency ablation compared with surveillance: systematic review and meta-analysis", Am J Gastroenterol, 112, pp.849~865 (2017)[DOI]
- Scholvinck DW, "Detection of lesions in dysplastic Barrett's esophagus by community and expert endoscopists", Endoscopy, 49, pp.113~120 (2017)
- Moss A, "Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit", Am J Gastroenterol, 105, pp.1276~1283 (2010)[DOI]
- Wani S, "Greater interobserver agreement by endoscopic mucosal resection than biopsy samples in Barrett's dysplasia", Clin Gastroenterol Hepatol, 8, pp.783~788 (2010)[DOI]
- Standards of Practice Committee, "Endoscopic eradication therapy for patients with Barrett's esophagus-associated dysplasia and intramucosal cancer", Gastrointest Endosc, 87, pp.907~931 (2018)[DOI]
- Pech O, "Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus", Gut, 57, pp.1200~1206 (2008)[DOI]
- Shaheen NJ, "Radiofrequency ablation in Barrett's esophagus with dysplasia", N Engl J Med, 360, pp.2277~2288 (2009)[DOI]
- Phoa KN, "Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and lowgrade dysplasia: a randomized clinical trial", JAMA, 311, pp.1209~1217 (2014)[DOI]
- Cotton CC, "Development of evidence based surveillance intervals following radiofrequency ablation of Barrett's esophagus", Gastroenterology (2018)[DOI]
- van Vilsteren FG, "Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study", Endoscopy, 45, pp.516~525 (2013)[DOI]
- Komanduri S, "Recurrence of Barrett's esophagus is rare following endoscopic eradication therapy coupled with effective reflux control", Am J Gastroenterol, 112, pp.556~566 (2017)[DOI]
- Qumseya BJ, "Adverse events after radiofrequency ablation in patients with Barrett's esophagus: a systematic review and meta-analysis", Clin Gastroenterol Hepatol, 14, pp.1086~1095 (2016)[DOI]
